Campbell & Co Investment Adviser’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
VPM
VCM
B
Campbell & Co Investment Adviser's NEO Position: Q1 2026 in Review
Campbell & Co Investment Adviser opened a new position in NeoGenomics (NEO) in Q1 2026: 350,891 shares worth $2.6M. The stake represents 0.15% of the portfolio and ranks #204 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in NEO as recently as Q3 2025.
Campbell & Co Investment Adviser first reported a position in NEO in Q2 2016 and has held it in 20 quarters since. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.
- Campbell & Co Investment Adviser held 350,891 shares of NeoGenomics worth $2.6M as of Q1 2026.
- NeoGenomics was a new Campbell & Co Investment Adviser position in Q1 2026.
- NeoGenomics made up 0.15% of Campbell & Co Investment Adviser's portfolio in Q1 2026, its #204 holding.
- Campbell & Co Investment Adviser first reported a position in NeoGenomics in Q2 2016 and has held it in 20 quarters since.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.